These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1473 related items for PubMed ID: 16139578

  • 41. Bone mass and structure are enhanced following a 2-year randomized controlled trial of exercise in prepubertal boys.
    MacKelvie KJ, Petit MA, Khan KM, Beck TJ, McKay HA.
    Bone; 2004 Apr; 34(4):755-64. PubMed ID: 15050908
    [Abstract] [Full Text] [Related]

  • 42. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A, Murray RD, Shalet SM.
    Horm Res; 2004 Apr; 62 Suppl 3():35-41. PubMed ID: 15539797
    [Abstract] [Full Text] [Related]

  • 43. Relationships of acylated and des-acyl ghrelin levels to bone mineralization in obese children and adolescents.
    Pacifico L, Anania C, Poggiogalle E, Osborn JF, Prossomariti G, Martino F, Chiesa C.
    Bone; 2009 Aug; 45(2):274-9. PubMed ID: 19393347
    [Abstract] [Full Text] [Related]

  • 44. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Aug; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 45. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [Abstract] [Full Text] [Related]

  • 46. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 47. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O, Lindberg A, Swedish KIGS National Board.
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [Abstract] [Full Text] [Related]

  • 48. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [Abstract] [Full Text] [Related]

  • 49. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J, Kuenkler M, Schneider HJ, Dieterle C, Schopohl J.
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [Abstract] [Full Text] [Related]

  • 50. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
    Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R.
    J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
    [Abstract] [Full Text] [Related]

  • 51. Prospective ten-month exercise intervention in premenarcheal girls: positive effects on bone and lean mass.
    Morris FL, Naughton GA, Gibbs JL, Carlson JS, Wark JD.
    J Bone Miner Res; 1997 Sep; 12(9):1453-62. PubMed ID: 9286762
    [Abstract] [Full Text] [Related]

  • 52. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.
    Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cédoz JP, Wendling D.
    Rheumatology (Oxford); 2005 Jan; 44(1):120-5. PubMed ID: 15466894
    [Abstract] [Full Text] [Related]

  • 53. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [Abstract] [Full Text] [Related]

  • 54. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M.
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [Abstract] [Full Text] [Related]

  • 55. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency.
    Sartorio A, Agosti F, De Col A, Mazzilli G, Marazzi N, Busti C, Galli R, Lafortuna CL.
    Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999
    [Abstract] [Full Text] [Related]

  • 56. Effect of one-year growth hormone therapy on body composition and cardio-metabolic risk in Indian children with growth hormone deficiency.
    Khadilkar V, Ekbote V, Kajale N, Khadilkar A, Chiplonkar S, Kinare A.
    Endocr Res; 2014 Jan; 39(2):73-8. PubMed ID: 24066645
    [Abstract] [Full Text] [Related]

  • 57. The IGF-I response to growth hormone is related to body mass index in short children with normal weight.
    Roman R, Iniguez G, Lammoglia JJ, Avila A, Salazar T, Cassorla F.
    Horm Res; 2009 Jan; 72(1):10-4. PubMed ID: 19571554
    [Abstract] [Full Text] [Related]

  • 58. [The effect of one year therapy with recombinant human growth hormone (rhGH) on growth velocity, calcium-phosphorus metabolism, bone mineral density and changes in body composition in children with growth hormone deficiency (GHD)].
    Zak T, Basiak A, Zubkiewicz-Kucharska A, Noczyńska A.
    Pediatr Endocrinol Diabetes Metab; 2010 Jan; 16(1):39-43. PubMed ID: 20529605
    [Abstract] [Full Text] [Related]

  • 59. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M, Payer J.
    Cas Lek Cesk; 2010 Jan; 149(5):211-6. PubMed ID: 20629339
    [Abstract] [Full Text] [Related]

  • 60. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G.
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 74.